Middle East Healthcare Company (4009.SR) SAU
33.14
+0.62(+1.91%)
Currency In SAR
- General
- Statistics
- Historical Data
- Profile
- Financials
33.14
+0.62(+1.91%)
Currency In SAR
| Market Cap | 3B |
| Enterprise Value | 5.51B |
| P/E Ratio | 18.17 |
| PEG Ratio | -0.32 |
| Price/Sales Ratio | 0.97 |
| Price/Book Ratio | 1.6 |
| Enterprise/Revenue | 1.78 |
| Enterprise/EBITDA | 11.26 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.05 |
| Operating Margin | 0.11 |
| Return On Assets | 0.03 |
| Return On Equity | 0.09 |
| Revenue | 3.1B |
| Revenue/Share | 34.15 |
| Gross Profit | 1.16B |
| EBITDA | 636.54M |
| Net Income | 301.88M |
| Diluted EPS | 3.28 |
| Total Cash | 24.1M |
| Total Cash/Share | 0.26 |
| Total Debt | 2.56B |
| Total Debt/Equity | 1.35 |
| Current Ratio | 1.48 |
| Book Value Per Share | 21.28 |
| 52-Week Change | -42.66 |
| 52-Week High | 60.7 |
| 52-Week Low | 28.66 |
| Moving Average 50 Days | 35.73 |
| Moving Average 200 Days | 40.77 |
| Average Volume | 802,418 |
| Shares Outstanding | 92.04M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.5 |
| Trailing Annual Dividend Yield | 1.51 |
| Payout Ratio | 0.27 |
| Last Split Factor | N/A |
| Last Split Date | N/A |